Konarka Appoints Daniel Geffken as Chief Financial Officer; Senior Executive Brings 25 Years of Financial and Operational Management Experience to the Company
"Daniel's talents are ideally suited to Konarka at this stage in our development," stated Howard Berke, Chairman and Chief Executive Officer. "He brings a depth of experience to the organization, and his proven track record of successfully growing venture-backed and publicly-held companies will help us to build Konarka into a major player in the solar energy field."
“Daniel's talents are ideally suited to Konarka at this stage in our development”
Most recently, Geffken was Senior Vice President and Chief Financial Officer at OmniSonics Medical Technologies, Inc., a venture-backed medical device company. Prior to OmniSonics, Geffken was Senior Vice President and Chief Financial Officer at Transkaryotic Therapies, Inc., a publicly-held biotechnology company that was acquired by Shire Pharmaceuticals plc in 2005 for $1.8 billion. Geffken also worked in the leveraged buyout and public accounting industries. He holds an M.B.A. from Harvard Business School and a B.S. in Economics from The Wharton School, University of Pennsylvania.
"I am delighted to join Konarka's senior management team," commented Daniel Geffken. "The Company's powerful technology has the potential to form the basis of a truly great company in the field of clean, renewable energy. As we drive toward commercialization, we will endeavor to establish the operational infrastructure to transform this potential into reality."
About Konarka Technologies, Inc.
Konarka builds products that convert light to energy - anywhere. Konarka is the leading developer of polymer photovoltaic products that provide a source of renewable power in a variety of form factors for commercial, industrial, government and consumer applications. Konarka's photovoltaic nanotechnology is focused on delivering lightweight, flexible, scalable and manufacturable products. Konarka has a broad portfolio of patents, technology licenses and an accomplished technical team. Nobel Laureate Professor Alan Heeger (UC Santa Barbara) is a director, co-founder and chief scientist for Konarka. Konarka Technologies is headquartered in Lowell, Mass., U.S.A., with European headquarters in Nuremberg, Germany, and research and development facilities in Austria and Switzerland. For additional information, visit http://www.konarka.com.
All trademarks recognized.